Sort
15,273 grants matching “antimicrobial resistance”
Bioorganic Approaches Toward Novel Antimicrobial Agents Against Gram-Negative Bacteria
$298,678Steven D. Townsend · Vanderbilt University · R35 · FY2020 · GM
Regulation of Bacterial Two-Component Signaling by Small Membrane Proteins
$298,664Mark D Goulian · University Of Pennsylvania · R01 · FY2012 · GM
A Multivalent Lipoprotein Vaccine to Prevent S. aureus Cutaneous Infections
$298,656Lisa Herron-Olson · Syntiron, Llc. · R43 · FY2015 · AI
A mobile health tool to improve antibiotic stewardship among village doctors in Bangladesh
$298,640Daniel Ted Leung · University Of Utah · R33 · FY2024 · HD
Molecular analysis of accurate ribosomal translocation
$298,593Kurt L Fredrick · Ohio State University · R01 · FY2020 · GM
Therapeutic cells encapsulation and delivery for improved healing of chronic diabetic wounds
$298,530Manav Mehta · Gel4med, Inc. · R43 · FY2017 · DK
Pulmonary Delivery of Antibiotics Co-crystalized with Cyclodextrin-based Metal Organic Frameworks to Treat Non-Tuberculous Mycobacterial (NTM) Infections
$298,530Xiang Gao · Scientific Horizons Consulting Llc · R43 · FY2024 · AI
Microbiological Characterization and Mitigation of Bioaerosols in CAFOs
$298,528Norman R Pace · University Of Colorado · R01 · FY2009 · OH
Development of Novel S. aureus Antibiotics with Reduced Resistance Susceptibility
$298,502Michael E. Johnson · Novalex Therapeutics, Inc. · R41 · FY2015 · AI
Development of Novel S. aureus Antibiotics with Reduced Resistance Susceptibility
$298,502Michael E. Johnson · Novalex Therapeutics, Inc. · R41 · FY2014 · AI
Synthetic Ligands for Modulating Bacterial Communication
$298,498Helen E. Blackwell · University Of Wisconsin-Madison · R01 · FY2014 · GM
Novel therapeutic monoclonal antibody targeting SP-R210 isoforms to prevent influenza disease progression and expedite resolution of comorbidities
$298,498Andy Agrawal · Respana Therapeutics, Inc. · R41 · FY2018 · AI
Regulation of Bacterial Two-Component Signaling by Small Membrane Proteins
$298,461Mark D Goulian · University Of Pennsylvania · R01 · FY2014 · GM
Regulation by Botanicals of Pathogen-Specific Immune Def
$298,426Sloan-Kettering Institute For Cancer Res · P50 · FY2005 · AT
Collaborative Research: Rational Design and Mechanistic Understanding of Carbon-Based Hybrid Nanostructures for Potent Microbicidal Function
$298,418Ya-Ping Sun · Clemson University · · FY2021 · MPS
Phase I Clinical Trial to Evaluate a Neisseria Gonorrhoeae Therapeutic Candidate
$298,404Michael Cohen-Wolkowiez · Duke University · N01 · FY2015 · AI
Regulation of Bacterial Two-Component Signaling by Small Membrane Proteins
$298,355Mark D Goulian · University Of Pennsylvania · R01 · FY2015 · GM
Cross-talk among mosquito and mammalian immune factors
$298,344Shirley Luckhart · University Of California At Davis · R01 · FY2008 · AI
Recognition and Signaling During Infection in Drosphila
$298,333Jules A Hoffman · Massachusetts General Hospital · P01 · FY2008 · AI
Development of Single Agent Antibiofilm Antibiotics
$298,326Joshua G. Pierce · Synoxa Sciences, Inc · R41 · FY2020 · AI
Mechanisms of risk for sulfoniamide hypersensitivity
$298,309Lauren A Trepanier · University Of Wisconsin-Madison · R01 · FY2014 · GM
Role of PA4878 in biofilm antimicrobial resistance
$298,239Karin Sauer · State University Of Ny,Binghamton · R01 · FY2010 · AI
Genetic Functions of an Enterococcal R Factor
$298,211Gary M Dunny · University Of Minnesota · R01 · FY2013 · GM
Molecular analysis of accurate ribosomal translocation
$298,191Kurt L Fredrick · Ohio State University · R01 · FY2021 · GM
Rapid, Highly Multiplexed and Sensitive Blood Test for Drug-resistant Bacteria
$298,111Taiho Kim · Nesher Technologies, Inc. · R43 · FY2010 · AI